IIPTA Article Archive
Magnify your Career, Income, Brand and Reach through Intellectual Property.
Subscribe To Get Updates.
Canada’s Opioid crisis sparked by a little known patent
Like the millions of patent applications before it, the one filed in Gatineau, Que., by the Canadian subsidiary of U.S. drug giant Purdue Pharma promised remarkable things. The company’s researchers had “surprisingly” discovered a [...]
Where we stand with Tradesecrets Enforcement
Trade secrets are important to cybersecurity because many data breaches involve trade secret theft. The Defend Trade Secrets Act of 2016 (DTSA) amended the Espionage Act of 1996 to provide a federal private right [...]
America’s patent system favors low tech
The U.S. patent system is not in a good place today. Patents are worth substantially less than they were a decade ago, patents are much easier to challenge thanks to the high kill rate [...]
Over Half the U.S. Utility Patents Issued Annually are Software Related
The Supreme Court’s most recent ruling on the issue, Alice Corp. v. CLS Bank has left the IP bar without a clear, reliable test to determine when exactly a software (or computer-implemented) claim is [...]
IPR Can Support Finding of Prosecution Disclaimer
Aylus Networks, Inc. (“Aylus”) owns the ’412 patent, which “provides systems and methods for implementing digital home networks having a control point located on a wide area network.” The patent teaches various network architectures [...]
AbbVie Loses Key Humira Patent In Battle With Small
Coherus Biosciences stock rocketed to a month high wednesday after a U.S. BOARD tossed out a key patent protecting AbbVie's most important drug, arthritis medication Humira, thus clearing an obstacle from a similar treatment [...]